Merit Medical Systems | MMSI - Operating Profit


Merit Medical Systems reported $44.16M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
3M USD 1.55B 337M Mar/2026
Abbott USD 1.85B 399M Mar/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Anika Therapeutics USD 646K 3.88M Dec/2025
AtriCure USD 526K 1.96M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Cooper Companies USD -31M 243.8M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Globus Medical USD 164M 17.31M Mar/2026
Haemonetics USD 67.4M 8.9M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Medtronic USD 2.09B 354M Mar/2026
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Olympus JPY 26.87B 1.14B Mar/2026
Pfizer USD 4.99B 340M Mar/2026
STAAR Surgical USD 17.4M 28.34M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Surmodics USD 58K 5.7M Jun/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026